Fact sheet: Pictet Biotech

Fund information

Fund name
Pictet Biotech I dy GBP
Fund company manager
Pictet Asset Management (Europ
Fund type
SIB
Fund manager(s)
Tazio Storni
since 26/05/2016
Lydia Haueter
since 26/05/2016
Fund objective
The sub-fund seeks capital growth by investing at least two-thirds of its total assets in the shares of particularly innovative companies operating in medical biotechnology. The investment universe is not restricted to a specific geographical zone. However, given the particularly innovative nature of the pharmaceutical industry in North America and Europe, the vast majority of investments will be made in this zone.
Benchmark
NASDAQ Biotechnology
Investment style
Growth
Investment method
Shares

Performance snapshot

Sector
Fund
Sector
Fund
Sector
Fund

Quick stats

1 Year return

7.47 %

1 Year rank in sector

-

Sector

FO Equity - Pharma Health & Biotech

Yield
-
Fund size

£ 1.5 b

FE Risk score

201

NAV
-
Discount/Premium
-
Gearing
-

Top in sector

Holdings snapshot

  • USA
    93.2%
  • UK
    2%
  • Netherlands
    1.3%
  • Belgium
    1.2%
  • Denmark
    1.1%
  • Health Care
    54.1%
  • Pharmaceuticals
    26.7%
  • Technology
    12.4%
  • Services
    6.6%
  • Money Market
    0.2%
  • US Equities
    93.2%
  • UK Equities
    2%
  • Dutch Equities
    1.3%
  • Belgian Equities
    1.2%
  • Danish Equities
    1.1%

Performance vs. Sector

Sector
Fund
Sector
Fund
Sector
Fund

Cumulative performance

1m6m1y3y5y
Fund4.72 %10.62 %7.47 %4.74 %93 %
Sector1.64 %5.37 %8.16 %0.43 %72.32 %
Rank within sector / / / / /
Quartile th th th th th th

Calendar performance

YTD-20182017201620152014
Fund12.75 %14.51 %-8.61 %18.02 %31.77 %
Sector9.47 %14.94 %-9.92 %7.24 %28.08 %
Rank within sector / / / / /
Quartile th th th th th th

Risk statistics

Alpha1.98
Beta1.24
Sharpe-0
Volatility20.87
Tracking error10.08
Information ratio0.13
R-Squared0.8

Price movement

52 week high677.38
52 week low540.71
Current bid price0
Current offer price0
Current mid price677.38

Holdings by region

  • 93.2% USA
  • 2% UK
  • 1.3% Netherlands
  • 1.2% Belgium
  • 1.1% Denmark
  • 1% Switzerland
  • 0.2% Money Market

Holdings by sector

  • 54.1% Health Care
  • 26.7% Pharmaceuticals
  • 12.4% Technology
  • 6.6% Services
  • 0.2% Money Market

Holdings by asset type

  • 93.2% US Equities
  • 2% UK Equities
  • 1.3% Dutch Equities
  • 1.2% Belgian Equities
  • 1.1% Danish Equities
  • 1% Swiss Equities
  • 0.2% Money Market

Individual holdings

  • 5.7% BIOGEN INC
  • 5.5% AMGEN INC
  • 5.4% CELGENE CORP
  • 5% ALEXION PHARMACEUTICALS INC
  • 5% VERTEX PHARMACEUTICALS INC
  • 4.9% GILEAD SCIENCES INC
  • 3.8% BIOMARIN PHARMACEUTICAL
  • 3.5% ILLUMINA INC
  • 3.5% INCYTE CORP
  • 3.5% REGENERON PHARMACEUTICALS INC